Polymorphisms in <i>RET</i> and Its Coreceptors and Ligands as Genetic Modifiers of Multiple Endocrine Neoplasia Type 2A
Fabienne Lesueur(Inserm), Bruce A.J. Ponder(University of Cambridge), Patricia Niccoli‐Sire(Hôpital de la Timone), Karl-Axel Svensson, Arancha Cebrián(Hospital Universitario Fundación Jiménez Díaz), Paul D.P. Pharoah(Cedars-Sinai Medical Center), S. Pinson(Hôpital Edouard Herriot), Jean Leyland(University of Cambridge), Mercedes Robledo(The University of Texas at San Antonio Health Science Center)
Cited by 52
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k